Safety, Tolerability, and Efficacy of MN-001 (Tipelukast) in Patients With Idiopathic Pulmonary Fibrosis
PHASE2This is a randomized, placebo-controlled, double-blind, 6-month study follo...
Location
Penn State University College of Medicine, Milton S. Hershey Medical Center
Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects
PHASE2This is a multi-center, proof-of-principle, open-label study designed to ev...
Location
Southern California Research Center
MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia
PHASE2The design of the Phase 2 clinical trial includes the following elements:
...
Status
Active Not Recruiting
Location
Jubilee Clinical Research, Inc.